ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of “Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges” in ...

As part of this MoU, Nyxoah and SSMC are engaged in initiatives aimed at positioning SSMC as a leading regional center for Genio therapy. These efforts are intended to support the development of a ...

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/ .

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial ...

“Michael's experience leading enterprise transformations makes him a strong addition to the Board,” said Kenneth H. Paulus, the non-executive Chairman of the Teladoc Health board. “As the company ...

About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ ...

ZUG, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the ...

XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com . A replay of each presentation will be available and archived on the site ...

MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate ...

Date/Time: Thursday, February 26, 2026, at 8:00 am ET ...

BriaCell originally secured the exclusive license from the University of Maryland, Baltimore County (“ UMBC ”) on August 2, 2022. The novel technology, originally developed by Suzanne ...